MedPath

Chromium nicotinate

Generic Name
Chromium nicotinate
Drug Type
Small Molecule
Chemical Formula
C18H12CrN3O6
CAS Number
64452-96-6
Unique Ingredient Identifier
A150AY412V

Overview

No overview information available.

Background

No background information available.

Indication

Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN), to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms .

Associated Conditions

No associated conditions information available.

FDA Approved Products

Vitrexyl
Manufacturer:PureTek Corporation
Route:ORAL
Strength:35 ug in 1 1
Approved: 2023/01/11
NDC:59088-164
Prometa
Manufacturer:PureTek Corporation
Route:ORAL
Strength:45 ug in 1 1
Approved: 2023/02/08
NDC:59088-172
Vitranol Fe
Manufacturer:PureTek Corporation
Route:ORAL
Strength:35 ug in 1 1
Approved: 2023/01/11
NDC:59088-173
Vitrexate FE
Manufacturer:PureTek Corporation
Route:ORAL
Strength:35 ug in 1 1
Approved: 2023/01/11
NDC:59088-168
Vitranol
Manufacturer:PureTek Corporation
Route:ORAL
Strength:35 ug in 1 1
Approved: 2023/01/11
NDC:59088-171

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath